Filing Details KESTRA MEDICAL TECHNOLOGIES, LTD. (NASDAQ:KMTS) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on July 28, 2026. The…
KESTRA MEDICAL TECHNOLOGIES, LTD. (NASDAQ:KMTS) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on July 28, 2026.
The Healthcare company's proxy statement provides information for shareholders ahead of the annual meeting, including board nominations, executive compensation, and proposals for shareholder vote.
KESTRA MEDICAL TECHNOLOGIES, LTD.'s stock currently trades at $23.86 with a market capitalization of $1.3B.
SEC filings provide mandatory disclosures that give investors access to the same material information available to institutional investors. Reviewing KESTRA MEDICAL TECHNOLOGIES, LTD.'s filings alongside price action and analyst commentary provides a more complete picture of the company's current situation.
All SEC filings for KESTRA MEDICAL TECHNOLOGIES, LTD. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View KMTS Stock Page
Browse all filings on our KMTS SEC filings page.
Public companies like KESTRA MEDICAL TECHNOLOGIES, LTD. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Current market data
NASDAQ · KMTS
$25.81
Down: -$0.76 · -2.86%
Live quote updated
Keep reading
analyst ·
price ·
analyst ·
sec_filing ·
